For millions of women across Europe, urinary incontinence is not just a medical inconvenience, it is a daily source of embarrassment, isolation, and lost quality of life. Many are told to manage it with pads, exercises, and patience. Younger women are frequently told something even harder to hear: that they are “too young for surgery.”
At GMS Cyprus, we have spent years looking for better answers. That search led our founder directly to the FEMSelect® EnPlace™ procedure and to bringing it to Cyprus and the European Union as quickly as possible.
What Is the EnPlace™ Procedure?
The FEMSelect® EnPlace™ is a minimally invasive, same-day procedure designed to treat stress urinary incontinence (SUI) and selected cases of pelvic organ prolapse in women. It takes approximately 30 minutes, requires no hospital stay, and results typically last 10 to 15 years, and for many women, a lifetime.
The procedure works by placing a small, soft supportive implant beneath the urethra to restore its natural support. Unlike traditional sling surgery, EnPlace™ does not require needles to pass behind the pubic bone or through the groin. There are no abdominal incisions, no mesh, and no removal of the uterus. The implant is positioned vaginally and secured with dissolvable stitches, working gently with the body’s own structures so the urethra stays closed during everyday activities: coughing, laughing, lifting, exercising.
Women are typically back to normal activities within days.
See official website about EnPlace™ for more infromation about the procedure.
Who Is It For?
The EnPlace™ procedure is suitable for women with stress urinary incontinence, which causes involuntary urine leakage during any activity that increases pressure on the bladder. It also addresses early-stage pelvic organ prolapse, which commonly accompanies weakened pelvic floor tissues.
Crucially, this procedure is appropriate for women of all ages, including younger women who have been turned away from traditional surgical options. If you have been told you are too young for surgery, or that you simply have to live with leakage, EnPlace™ may change that conversation entirely.
Why This Matters for Women in Europe
Until recently, the EnPlace™ method was only available in specialised centres in Israel and the United States. With over 6,000 procedures performed globally and four-year data showing a 92% surgical success rate, its clinical track record is well established.
GMS Cyprus is now the only provider in the European Union offering this procedure. This is not an accident. GMS founder identified EnPlace™ as a genuinely life-changing option for women who had exhausted the limited choices available to them in Europe, and moved immediately to make it accessible here.
The procedure is performed in Cyprus in partnership with the American Medical Center (AMC), the first medical centre in Europe to formally implement the EnPlace™ method. AMC’s clinical team brings deep expertise in minimally invasive gynaecological care, and their adoption of this technology reflects the same commitment to innovation that drives everything we do at GMS.
The GMS Cyprus Commitment: Finding What Women Actually Need
The GMS Cyprus founder has made it her life’s work to source cutting-edge technologies that deliver real, meaningful outcomes for patients, particularly in areas where women in Europe have historically been underserved.
Urinary incontinence is one of those areas. Despite affecting an enormous number of women of all ages (not just post-menopausal patients), it remains under-discussed, under-treated, and too often dismissed. Women are handed pads and told to do Kegel exercises. Those with symptoms that interfere with work, relationships, exercise, and sleep are frequently told to wait.
EnPlace™ changes this. A 30-minute, same-day procedure with results that can last a lifetime is not a small thing. For many of the women we work with, it represents the first time a concrete, fast, and minimally invasive solution has been within reach.
What to Expect: The GMS Approach
Every patient at GMS Cyprus receives a personalised consultation before any procedure. Our care team will review your medical history, confirm your candidacy for EnPlace™, and walk you through every step of the process. We handle the logistics: travel, accommodation, pre-operative assessment, and post-procedure follow-up, so that your focus can remain entirely on your health.
Because this procedure is performed on an outpatient basis, most patients travel to Cyprus, undergo the procedure, rest briefly, and return home within a short visit. Our multilingual care team is available throughout.
A note on availability: Device availability for the EnPlace™ procedure is strictly limited. Treatment slots fill quickly. If you are considering this procedure, we encourage you to contact us as early as possible.
Key Facts at a Glance
- Procedure time: Approximately 30 minutes
- Hospital stay: None, same-day procedure
- Technique: Minimally invasive, vaginal approach, no abdominal incisions
- Implant: Small, soft supportive device, no mesh
- Uterus: Preserved
- Results: Typically 10–15 years; often lifetime
- Global track record: Over 6,000 procedures performed, 92% surgical success rate at four years
- Who it helps: Women with stress urinary incontinence and selected pelvic organ prolapse cases, including younger women
- Available in EU: Exclusively through GMS Cyprus
Frequently Asked Questions
Yes. One of the most important aspects of this procedure is that it is appropriate for women of all ages. Women who have been told they are too young to undergo traditional incontinence surgery are often good candidates.
No. The EnPlace™ system is designed specifically to avoid the most invasive elements of traditional sling surgery. There are no needles passed through the groin, no mesh, and no abdominal incisions.
Most women return to normal daily activities within a few days. There is no lengthy hospital-based recovery.
GMS Cyprus is currently the only provider in the EU offering this procedure.
Contact our care team. We will arrange a pre-operative clinical assessment and review your case in full before any commitment is made.
Take the First Step
If you have been living with urinary incontinence, or if you have been told there is nothing that can be done for you yet, we want to hear from you. A 30-minute procedure should not be out of reach for women in Europe.
Contact the GMS Cyprus care team today to learn more about the FEMSelect® EnPlace™ procedure and secure your consultation.
GMS Cyprus is the exclusive EU provider of the FEMSelect® EnPlace™ procedure for the treatment of stress urinary incontinence and pelvic organ prolapse. All procedures are performed in partnership with the American Medical Center, Cyprus.
